As open enrollment ends, many people are tuning out. They could wind up with a surprise next year: higher costs and less access to health care providers.
Obamacare had its moment, but not until the faceoff’s final minutes. Front-runner Donald Trump again was not on the debate stage, leaving the other Republican presidential hopefuls to slug it out to break through and gain voters’ attention.
Colorado officials say they haven’t been able to stand up a program to import drugs from Canada because of drugmaker opposition — and the Biden administration’s inaction.
More than 2 million people a year have been sent notices that Social Security overpaid them and demanding they repay the money. That’s twice as many as the head of Social Security disclosed at a congressional hearing in October.
Long-term care options in the U.S. are costly, complex, and often inadequate. KFF Health News’ Jordan Rau and Reed Abelson of The New York Times host a Zoom panel to explore the challenges of providing — and affording — care.
States and counties look to expand programs that accept donations of unused surplus drugs from places like nursing homes and hospitals and redistribute them to low-income and uninsured residents.
The Supreme Court heard arguments over whether the Sacklers, the family behind Purdue Pharma — which marketed OxyContin — could claim immunity from future lawsuits without claiming bankruptcy.